Johnson & Johnson submits COVID-19 vaccine to WHO for emergency use listing
Story Date: 2/22/2021

 

Source: FOX NEWS, 2/20/21
 
Johnson & Johnson announced on Friday that it had submitted its coronavirus vaccine to the World Health Organization for emergency use listing. The vaccine, which is administered in a one-dose jab, is also pending emergency use authorization from the FDA.

"Our filing with the World Health Organization marks another important step in our effort to combat COVID-19 and also in our unwavering commitment to equitable access," Paul Stoffels, Johnson & Johnson vice chairman of the executive committee, and chief scientific officer, said in a news release. "If we are to end the global pandemic, life-saving innovations like vaccines must be within reach for all countries."

For more of this story, click here


























   Copyright © 2007 North Carolina Agribusiness Council, Inc. All Rights Reserved.
   All use of this Website is subject to our
Terms of Use Agreement and our Privacy Policy.